Watch Ticker

BioXcel Therapeutics, Inc. Common Stock

Go to BioXcel Therapeutics, Inc. Common Stock Website

$2.13

-0.41 (-16.14%)

Live

Previous Close

$2.54

Day Range

$0 - $0

Previous Day Range

$1.575 - $2.75

Market Cap

$8.3 million USD

Day Vol.

Previous Day Vol.

82.7 million

Currency

USD

Primary Exchange

Nasdaq

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeli...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Neuroendocrine Prostate Cancer Market Forecast Shows Accelerated CAGR Due to Diagnostic Advancements and Research Investment | DelveInsight

The neuroendocrine prostate cancer treatment market is expected to grow significantly between 2025-2034, driven by novel therapies and diagnostic advancements, despite challenges in treatment for older patients.

Related tickers: BTAI, AMGN, NVS.

Read Full Article

Bioxcel Therapeutics - BioXcel Therapeutics Announces Last Patient Last Visit in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia

BioXcel Therapeutics completed its SERENITY At-Home Phase 3 clinical trial for BXCL501, an investigational treatment for agitation in bipolar disorders and schizophrenia. The study enrolled over 200 patients across 22 sites, with topline data expected this month to support a potential supplemental New Drug Application.

Related tickers: BTAI.

Read Full Article

Trending Tickers

Please sign in to view